Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Retained Earnings for 14 consecutive years, with -$1.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings fell 5.14% year-over-year to -$1.3 billion; the trailing twelve-month figure through Jun 2026 stood at -$1.3 billion (down 5.14% YoY), and the FY2025 full-year result was -$1.3 billion, down 19.54% from the prior year.
• Retained Earnings declined to -$1.3 billion in Q2 2026 per TNDM's latest filing, from -$1.3 billion in the prior quarter.
• Across five years, Retained Earnings topped out at -$649.3 million in Q1 2022 and bottomed at -$1.3 billion in Q2 2026.
• Historically, Retained Earnings has averaged -$998.3 million across 5 years, with a median of -$1.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings grew 0.9% in 2022, then tumbled 33.79% in 2023.
• Over 5 years, Retained Earnings stood at -$729.2 million in 2022, then tumbled by 30.53% to -$951.8 million in 2023, then decreased by 10.09% to -$1.0 billion in 2024, then fell by 19.54% to -$1.3 billion in 2025, then slipped by 3.32% to -$1.3 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$1.3 billion, -$1.3 billion, and -$1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.